@article{934912cac19d46dbbdd5c6ce05c6eb61,
title = "From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Gu{\'e}rin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).",
keywords = "TUMOR-INFILTRATING LYMPHOCYTES, CARCINOMA IN-SITU, METASTATIC UROTHELIAL CARCINOMA, PHASE-II, SINGLE-ARM, HIGH-GRADE, OPEN-LABEL, RADICAL CYSTECTOMY, VACCINE, RISK",
author = "Susanne Deininger and Peter T{\"o}rzs{\"o}k and Michael Mitterberger and Maximilian Pallauf and David Oswald and Christian Deininger and Lukas Lusuardi",
note = "Deininger C: Department of Orthopedics and Traumatology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria; Spinal Cord Injury and Tissue Regeneration Center Salzburg, Institute of Tendon and Bone Regeneration, Paracelsus Medical University, 5020 Salzburg, Austria; Deininger S, T{\"o}rzs{\"o}k, Mitterberger, Pallauf, Oswald, Lusuardi : 1 Department of Urology and Andrology, Salzburg University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria. ",
year = "2022",
doi = "10.3390/cancers14030694",
language = "English",
volume = "14",
journal = "Cancers",
issn = "2072-6694",
publisher = "MDPI",
number = "3",
}